PrairieView Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$0 Hold
16
﹤0.01% 365
2025
Q1
$0 Hold
16
﹤0.01% 358
2024
Q4
$0 Hold
16
﹤0.01% 363
2024
Q3
$0 Hold
16
﹤0.01% 365
2024
Q2
$0 Hold
16
﹤0.01% 373
2024
Q1
$1K Hold
16
﹤0.01% 354
2023
Q4
$1K Hold
16
﹤0.01% 341
2023
Q3
$0 Hold
16
﹤0.01% 390
2023
Q2
$0 Hold
16
﹤0.01% 434
2023
Q1
$0 Hold
16
﹤0.01% 417
2022
Q4
$0 Hold
16
﹤0.01% 455
2022
Q3
$0 Sell
16
-20
-56% -$660 ﹤0.01% 435
2022
Q2
$1K Buy
36
+20
+125% +$736 ﹤0.01% 427
2022
Q1
$1K Hold
16
﹤0.01% 420
2021
Q4
$1K Hold
16
﹤0.01% 399
2021
Q3
$0 Buy
+16
New +$518 ﹤0.01% 371

Other funds holding CC

PrairieView Partners's CC Position: Q2 2025 in Review

PrairieView Partners held its Chemours (CC) position steady in Q2 2025 at 16 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #365.

PrairieView Partners first reported a position in CC in Q3 2021 and has held it in 16 quarters since. The position peaked at $1K in Q1 2024. 434 funds tracked by Wall St. Rank hold CC as of Q2 2025.

  • PrairieView Partners held 16 shares of Chemours worth $0 as of Q2 2025.
  • PrairieView Partners left its Chemours share count unchanged in Q2 2025.
  • Chemours made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #365 holding.
  • PrairieView Partners first reported a position in Chemours in Q3 2021 and has held it in 16 quarters since.
  • PrairieView Partners's Chemours position peaked at $1K in Q1 2024.
  • 434 funds tracked by Wall St. Rank held Chemours as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.